PIK3CA and non-small cell lung carcinoma: The dual inhibitor of PI3K/mTOR NVP-BEZ235 effectively inhibits the growth of gefitinib-resistant NSCLC cells by down-regulating PI3K/AKT/mTOR phosphorylation [91].